I recently worked at the Department of Radiation Oncology at Stony Brook University Hospital, where I focused on treating cancer through several radiation-based methods: radiation therapy, radiosurgery, and radiopharmaceuticals. After receiving my undergraduate degree in biology and religion at Duke University, I moved southwest to Alabama for medical school, then headed north to Stony Brook for my residency. I pride myself on my attention to detail, compassion, and commitment to providing the best possible patient care.
John D. Roberson, MD
About Dr. Roberson
"I have the unique opportunity to walk beside patients on this journey, providing a listening ear and helping them in any way I can."Dr. Roberson
American Society for Therapeutic Radiology and Oncology
Association of Residents in Radiation Oncology
American Medical Association
Christian Medical and Dental Association
2008 - 2012
Durham North Caolina
Bachelor of Science, Biology
Bachelor of Arts, Religion
University of Alabama at Birmingham
2012 - 2017
Doctor of Medicine
Stony Brook University Hospital
2017 - 2021
Stony Brook, New York
Residency, Department of Radiation Oncology
Charlotte, North Carolina
Find Dr. Roberson’s full list of publications on PubMed here.
- John D. Roberson, Omer L. Burnett, Nathaniel H. Robin. Radiogenomics: towards a personalized radiation oncology. Current Opinion in Pediatrics. 2016 Dec 1.
- John D. Roberson, Andrew M. McDonald, Craig J Baden, Chee Paul Lin, Rojymon Jacob, Omer L. Burnett. Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignancies. World Journal of Gastroenterology. 2016 Mar 14.
- Roberson J, Newman B, Ryu S. Chapter 49. Contemporary Radiation for Spinal Metastastasis and Spinal Cord Compression. Central Nervous System Metastases: Diagnosis and Treatment.
- Roberson II JD, Huang H, Hou W, Ryu S, Stessin A. NTCP modeling of hypothyroidism after supraclavicular-directed radiation therapy for breast cancer. Accepted for poster presentation at ASTRO, October 2020.
- Patel R, Roberson II JD, Hou W, Ryu S, Stessin A. Definitive stereotactic body radiation therapy in the local management of breast cancer. Accepted for poster presentation at ASTRO, October 2020.
- Roberson II JD, Patel R, Xu Z, Ryu S, Valentine E. Weekly high-dose rate brachytherapy via surface applicator for non-melanoma skin cancers in the elderly. Accepted for poster presentation at ASTRO, October 2020.
- Huang H, Roberson II JD, Hou W, Ryu S, Stessin A. Thyroid volume changes following adjuvant radiation therapy for breast cancer. Accepted for poster presentation at ASTRO, October 2020.
- Kahn D, Roberson J, Xu Z, Kim J, Lu S, Hsia T, Qian X, Ryu S. Effects of tissue inhomogeneity and applicator physical properties on 3-D HDR tandem and ovoid treatment plans. AAPM, July 2020.
- Roberson II JD, McDonald AM, Baden CJ, Jacob R, Burnett III OL. Factors associated with radiographic response and overall survival following administration of yttrium-90 resin microspheres. ASTRO, October 2015.
- Roberson II JD, McDonald AM, Baden CJ, Jacob R, Burnett III OL. Factors associated with increased incidence of toxicities following administration of yttrium-90 resin microspheres. ASCO GI, January 2015.
- Roberson II JD, McDonald AM, Baden CJ, Jacob R, Burnett III OL. Factors associated with increased incidence of toxicities following administration of yttrium-90 resin microspheres. UAB Medical Student Research Day, October 2014.
- Baden CJ, Roberson JD, Jacob R, Burnett III OL. Effectiveness and toxicity of yttrium-90 microsphere brachytherapy. American Radium Society, April 2014.
- Roberson II JD, Xu X, Wang X-F. Identification of microRNAs affected by the TGFβ pathway in breast cancer metastasis. Duke Undergraduate Research Day, 2012.
- Roberson II JD, Swindle CS, Klug CA. Characterization of Hoxa5 isoforms in hematopoietic stem cells. UAB Summer Research Expo Poster Session, 2010.
- “Prospective Pilot Study of Stereotactic Body Radiation Therapy (SBRT) for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery” (Alexander Stessin, PI): Primary author of IRB protocol for a prospective investigator-initiated clinical trial using SBRT in the definitive setting for patients not undergoing primary surgical intervention, recently opened to accrual at our institution. August 2020 – present.
- “Integrated Clinical-Radiomic-Pathomic Analysis for Response Prediction in Patients Receiving Radiation for Brain Metastases” (Kartik Mani, PI): Participated in retrospective analysis and database creation of patients who received radiation in the treatment of brain metastases in conjunction with the Department of Biomedical Informatics. August 2020 – present.
- “Safety and Efficacy of Weekly Iridium-192 High-Dose Rate Brachytherapy in the Treatment of NonMelanoma Skin Cancers” (Edward Valentine, PI): Project lead in developing retrospective database of patients who received HDR dermal brachytherapy at our institution; conducted analysis and authored manuscript. February 2020 – present.
- “Safety and Efficacy of SBRT in Unresectable Breast Cancer” (Alexander Stessin, PI): Project lead in creating retrospective database of patients who received definitive SBRT to the breast in patients who did not receive primary surgical intervention; conducted analysis and authored manuscript. January 2020 – present.
- “Retrospective Case Report of Rhabdomyosarcoma Treated with Y-90 Microspheres and EBRT” (Alexander Stessin, PI): Supervised medical student in reviewing clinical case and manuscript development regarding a novel treatment regimen for rhabdomyosarcoma diffusely involving the liver. November 2019 – present.
- “Review of Breast Cancer Patients Treated with Adjuvant Radiation Including Supraclavicular Regions” (Alexander Stessin, PI): Project lead in developing retrospective database of patients who received supraclavicular-directed radiation therapy for breast cancer to be used in multiple research projects. Supervised medical student in the Scholarly Concentrations Program in conducting outcomes analysis and manuscript development. Resulted in two manuscripts under consideration at peer-reviewed journals. Funding: Scholarly Concentrations Program of the Renaissance School of Medicine, Stony Brook University, $2400. September 2019 – present